COVID-19 UPDATE

Our contribution to supporting our customers, colleagues and our communities in this public health crisis

At Berthold, supporting our customers is a key priority, and our global teams are hard at work to avoid disruptions from the COVID-19 virus while at the same time acting responsibly to do what we can to prevent further spread. Our Risk Management Program that incorporates Business Continuity Plans for all our critical activities, risk assessments, and crisis-management protocols, strives to achieve uninterrupted supply to our customers. We are currently able to meet all customer expectations for product supply and availability.

Our executive staff are meeting regularly to monitor activities. We continue to closely watch and assess the evolving situation and will be diligent about communicating with affected customers regarding shipment timing or other issues resulting from this situation.

MEASURES TO REDUCE THE SPREAD OF COVID-19

Our customers, colleagues and communities are at the heart of what we do and with the rapidly developing Coronavirus situation we are taking the responsible measures needed to protect all of us.

We´re following RKI (Robert-Koch-Institute), the Federal Ministry of Health and WHO recommendations and guidelines to reduce the spread of COVID-19.

Focus on hygiene guidelines and social distancing best practises

Wash hands frequently

Avoid shaking hands

Keep a minimum distance of at least 1.5 m to other persons

Keep hands away from face and avoid touching mouth, nose and eyes

Stay at home when you´re sick

Focus on employee training and comprehensive site preparedness

Returnees from risk areas and Covid-19 suspected cases are not allowed to enter the company premises

Participation in trade fairs or training courses is to be refrained until further notice

No more external visitors are received, unless their visit is absolutely necessary for the continuation of essential business processes

SUPPORTING OUR CUSTOMERS

Our teams are hard at work to minimize the risk of potential disruption and we are currently able to meet all customer expectations for product supply and availability. All our manufacturing sites are operating at normal capacity.

Focus on leveraging our capabilities to support our customers

Expanding digital remote support activities

Our sales representatives refrain from any non-essential customer visits while being available to our customers working normal business hours as usual

RESEARCH SOLUTIONS FOR 2019 CORONAVIRUS SARS-CoV-2

Our solutions for SARS-CoV-2 (COVID-19) research help you to automate and standardize repetitive steps around the development and performance of in vitro microplate assays. We are ready to support your research by offering various technologies and system solutions that can help you to develop new treatments and vaccines against COVID-19 faster.

In order to make your Internet experience safer and as agreeable as possible, you should update your browser here to a new version.
The update is free. If you are using this PC at work, you should contact your IT administrator.
Please note that due to the outdated browser this website may not display correctly.